SHIP (Selinexor in Hormone Insensitive Prostate Cancer)
Clinical trial NCT02146833 · TERMINATED
Trial details
- NCT number
- NCT02146833
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2016-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.